 Kenneth Hurt
Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lacerations | 5 | 2023 | 35 | 3.050 |
Why?
| | Nitric Oxide Synthase Type I | 6 | 2020 | 28 | 2.120 |
Why?
| | Obstetric Labor Complications | 4 | 2023 | 34 | 2.090 |
Why?
| | Myometrium | 4 | 2020 | 39 | 1.550 |
Why?
| | Adiponectin | 2 | 2025 | 244 | 1.350 |
Why?
| | Labor, Obstetric | 2 | 2022 | 61 | 1.290 |
Why?
| | Parturition | 3 | 2022 | 71 | 1.250 |
Why?
| | Nurse Midwives | 2 | 2020 | 36 | 1.180 |
Why?
| | Pregnancy | 16 | 2025 | 6763 | 1.180 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2020 | 136 | 0.980 |
Why?
| | Delivery, Obstetric | 6 | 2023 | 144 | 0.900 |
Why?
| | Dystocia | 2 | 2022 | 11 | 0.890 |
Why?
| | Cystathionine gamma-Lyase | 2 | 2020 | 13 | 0.870 |
Why?
| | General Practitioners | 1 | 2023 | 28 | 0.840 |
Why?
| | Hydrogen Sulfide | 2 | 2020 | 44 | 0.820 |
Why?
| | Cesarean Section | 3 | 2022 | 184 | 0.790 |
Why?
| | Uterine Artery | 2 | 2020 | 79 | 0.780 |
Why?
| | Hydrocortisone | 1 | 2025 | 322 | 0.770 |
Why?
| | Ileum | 2 | 2020 | 119 | 0.750 |
Why?
| | Nitric Oxide | 4 | 2020 | 915 | 0.740 |
Why?
| | Perineum | 4 | 2023 | 32 | 0.730 |
Why?
| | Premature Birth | 1 | 2025 | 333 | 0.700 |
Why?
| | Leptin | 2 | 2020 | 236 | 0.700 |
Why?
| | Penile Erection | 2 | 2012 | 7 | 0.650 |
Why?
| | Estradiol | 2 | 2020 | 521 | 0.650 |
Why?
| | Gasotransmitters | 1 | 2019 | 1 | 0.640 |
Why?
| | Umbilical Arteries | 1 | 2020 | 55 | 0.630 |
Why?
| | Gastrointestinal Motility | 1 | 2019 | 27 | 0.630 |
Why?
| | Fertilization | 1 | 2019 | 44 | 0.620 |
Why?
| | Cysteine | 1 | 2020 | 204 | 0.610 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 197 | 0.590 |
Why?
| | Budd-Chiari Syndrome | 1 | 2018 | 5 | 0.590 |
Why?
| | Dysarthria | 1 | 2018 | 10 | 0.590 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2020 | 261 | 0.590 |
Why?
| | Ovary | 1 | 2020 | 221 | 0.580 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2018 | 52 | 0.560 |
Why?
| | Parity | 1 | 2018 | 126 | 0.550 |
Why?
| | Anal Canal | 4 | 2023 | 97 | 0.540 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2019 | 437 | 0.530 |
Why?
| | Pregnancy, Abdominal | 1 | 2016 | 2 | 0.510 |
Why?
| | Muscle Contraction | 1 | 2019 | 424 | 0.510 |
Why?
| | Prenatal Diagnosis | 1 | 2018 | 201 | 0.510 |
Why?
| | Amino Acids | 1 | 2020 | 497 | 0.500 |
Why?
| | Methotrexate | 1 | 2016 | 260 | 0.460 |
Why?
| | Obstetrics | 1 | 2016 | 163 | 0.440 |
Why?
| | Penis | 3 | 2012 | 36 | 0.440 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 565 | 0.440 |
Why?
| | Phosphorylation | 4 | 2020 | 1759 | 0.420 |
Why?
| | Education, Medical, Undergraduate | 1 | 2016 | 188 | 0.420 |
Why?
| | Physicians | 2 | 2023 | 910 | 0.420 |
Why?
| | Female | 21 | 2025 | 73304 | 0.420 |
Why?
| | Mice | 13 | 2024 | 17787 | 0.390 |
Why?
| | Cyclic AMP | 1 | 2012 | 234 | 0.370 |
Why?
| | Neurons | 2 | 2019 | 1590 | 0.370 |
Why?
| | Uterus | 3 | 2019 | 215 | 0.370 |
Why?
| | Mice, Inbred C57BL | 8 | 2024 | 5757 | 0.360 |
Why?
| | Students, Medical | 1 | 2016 | 348 | 0.360 |
Why?
| | Homocystinuria | 2 | 2024 | 71 | 0.350 |
Why?
| | Pregnancy Complications | 1 | 2015 | 527 | 0.340 |
Why?
| | Communication | 1 | 2016 | 879 | 0.330 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 938 | 0.330 |
Why?
| | Animals | 16 | 2024 | 36940 | 0.320 |
Why?
| | Taurine | 2 | 2020 | 46 | 0.310 |
Why?
| | Humans | 22 | 2025 | 137585 | 0.270 |
Why?
| | Liver | 3 | 2024 | 1943 | 0.270 |
Why?
| | NG-Nitroarginine Methyl Ester | 2 | 2020 | 48 | 0.260 |
Why?
| | Mice, Knockout | 5 | 2020 | 3015 | 0.240 |
Why?
| | Glutathione | 2 | 2020 | 356 | 0.230 |
Why?
| | Tetrahydrofolate Dehydrogenase | 1 | 2024 | 23 | 0.220 |
Why?
| | Tetrahydrofolates | 1 | 2024 | 18 | 0.220 |
Why?
| | Cystathionine beta-Synthase | 2 | 2024 | 71 | 0.220 |
Why?
| | Alternative Splicing | 1 | 2006 | 229 | 0.210 |
Why?
| | Young Adult | 4 | 2025 | 13209 | 0.210 |
Why?
| | Betaine | 2 | 2024 | 73 | 0.200 |
Why?
| | Pilot Projects | 2 | 2020 | 1710 | 0.200 |
Why?
| | Risk Factors | 3 | 2022 | 10388 | 0.190 |
Why?
| | Episiotomy | 1 | 2022 | 3 | 0.190 |
Why?
| | Obesity | 1 | 2015 | 2992 | 0.190 |
Why?
| | Rats | 6 | 2019 | 5647 | 0.190 |
Why?
| | Oxidation-Reduction | 2 | 2024 | 1060 | 0.190 |
Why?
| | Tandem Mass Spectrometry | 1 | 2025 | 532 | 0.180 |
Why?
| | Educational Status | 1 | 2023 | 470 | 0.180 |
Why?
| | Muscle, Smooth | 2 | 2019 | 155 | 0.180 |
Why?
| | Models, Theoretical | 1 | 2025 | 578 | 0.180 |
Why?
| | Estrogens | 2 | 2020 | 367 | 0.170 |
Why?
| | Infant, Newborn | 3 | 2022 | 6079 | 0.170 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2020 | 7 | 0.170 |
Why?
| | Adult | 5 | 2025 | 37929 | 0.170 |
Why?
| | Receptors, Adiponectin | 1 | 2019 | 19 | 0.160 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2020 | 132 | 0.160 |
Why?
| | Ovariectomy | 1 | 2020 | 152 | 0.160 |
Why?
| | Pituitary Gland | 1 | 2020 | 148 | 0.160 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5472 | 0.160 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 114 | 0.160 |
Why?
| | Cyclic GMP | 1 | 2019 | 93 | 0.160 |
Why?
| | Placentation | 1 | 2019 | 45 | 0.160 |
Why?
| | Family Practice | 1 | 2023 | 464 | 0.160 |
Why?
| | Cervix Uteri | 1 | 2019 | 48 | 0.160 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 124 | 0.160 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 92 | 0.150 |
Why?
| | Betaine-Homocysteine S-Methyltransferase | 1 | 2019 | 11 | 0.150 |
Why?
| | Carbon Monoxide | 1 | 2019 | 81 | 0.150 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2020 | 283 | 0.150 |
Why?
| | Placental Circulation | 1 | 2019 | 71 | 0.150 |
Why?
| | Progesterone | 1 | 2020 | 254 | 0.150 |
Why?
| | Electric Stimulation | 2 | 2012 | 264 | 0.150 |
Why?
| | Alanine | 1 | 2019 | 152 | 0.150 |
Why?
| | Brachial Artery | 1 | 2020 | 205 | 0.150 |
Why?
| | Mutation | 2 | 2020 | 3958 | 0.150 |
Why?
| | Extraction, Obstetrical | 1 | 2018 | 1 | 0.140 |
Why?
| | Prostaglandins | 2 | 2015 | 97 | 0.140 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 285 | 0.140 |
Why?
| | Protein Kinases | 1 | 2019 | 319 | 0.140 |
Why?
| | Oxytocin | 1 | 2018 | 51 | 0.140 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 416 | 0.140 |
Why?
| | Case-Control Studies | 1 | 2025 | 3556 | 0.130 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2691 | 0.130 |
Why?
| | Homeostasis | 1 | 2020 | 621 | 0.130 |
Why?
| | Gestational Age | 1 | 2020 | 910 | 0.130 |
Why?
| | Hemoperitoneum | 1 | 2016 | 12 | 0.130 |
Why?
| | Stress, Psychological | 1 | 2025 | 1100 | 0.130 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2139 | 0.120 |
Why?
| | Pregnancy, Ectopic | 1 | 2016 | 53 | 0.120 |
Why?
| | Uterine Contraction | 1 | 2015 | 17 | 0.120 |
Why?
| | Injections, Intramuscular | 1 | 2016 | 129 | 0.120 |
Why?
| | Ligaments | 1 | 2016 | 60 | 0.120 |
Why?
| | Receptors, Oxytocin | 1 | 2015 | 23 | 0.120 |
Why?
| | Delayed Diagnosis | 1 | 2016 | 91 | 0.120 |
Why?
| | Adipokines | 1 | 2015 | 49 | 0.120 |
Why?
| | Cyclooxygenase 2 | 1 | 2016 | 178 | 0.120 |
Why?
| | Endotoxemia | 1 | 2016 | 86 | 0.120 |
Why?
| | Video Recording | 1 | 2016 | 180 | 0.120 |
Why?
| | Observer Variation | 1 | 2016 | 343 | 0.120 |
Why?
| | Pelvis | 1 | 2016 | 102 | 0.120 |
Why?
| | Postpartum Period | 1 | 2018 | 340 | 0.120 |
Why?
| | Women's Health | 1 | 2018 | 372 | 0.110 |
Why?
| | Abdominal Pain | 1 | 2016 | 145 | 0.110 |
Why?
| | Clinical Clerkship | 1 | 2016 | 101 | 0.110 |
Why?
| | Cells, Cultured | 2 | 2020 | 4193 | 0.110 |
Why?
| | Infant, Newborn, Diseases | 1 | 2016 | 113 | 0.110 |
Why?
| | Biopsy | 1 | 2018 | 1129 | 0.110 |
Why?
| | Fetal Diseases | 1 | 2016 | 173 | 0.110 |
Why?
| | Models, Animal | 1 | 2016 | 384 | 0.110 |
Why?
| | Vagina | 1 | 2016 | 187 | 0.110 |
Why?
| | Spleen | 1 | 2016 | 514 | 0.110 |
Why?
| | Signal Transduction | 2 | 2019 | 5079 | 0.110 |
Why?
| | Dinitrobenzenes | 1 | 2013 | 5 | 0.110 |
Why?
| | Priapism | 1 | 2013 | 11 | 0.110 |
Why?
| | Cholesterol | 1 | 2015 | 410 | 0.110 |
Why?
| | Educational Measurement | 1 | 2016 | 289 | 0.100 |
Why?
| | Biomarkers | 1 | 2025 | 4149 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 3 | 2016 | 2486 | 0.100 |
Why?
| | Colforsin | 1 | 2012 | 53 | 0.100 |
Why?
| | Logistic Models | 1 | 2018 | 2074 | 0.100 |
Why?
| | Electronic Health Records | 1 | 2020 | 1069 | 0.100 |
Why?
| | Psychometrics | 1 | 2016 | 720 | 0.090 |
Why?
| | Ultrasonography | 1 | 2016 | 759 | 0.090 |
Why?
| | Databases, Factual | 1 | 2018 | 1357 | 0.090 |
Why?
| | Serine | 1 | 2012 | 141 | 0.090 |
Why?
| | Thioredoxins | 1 | 2011 | 30 | 0.090 |
Why?
| | Laparoscopy | 1 | 2016 | 466 | 0.090 |
Why?
| | Retrospective Studies | 2 | 2020 | 15657 | 0.090 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 131 | 0.080 |
Why?
| | Tacrolimus | 1 | 2011 | 199 | 0.080 |
Why?
| | Blotting, Western | 1 | 2012 | 1226 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 5742 | 0.080 |
Why?
| | Enzyme Inhibitors | 1 | 2012 | 840 | 0.080 |
Why?
| | Clinical Competence | 1 | 2016 | 1118 | 0.070 |
Why?
| | Algorithms | 1 | 2016 | 1704 | 0.070 |
Why?
| | Macrophages | 1 | 2016 | 1547 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3284 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1738 | 0.070 |
Why?
| | Colorado | 1 | 2018 | 4565 | 0.070 |
Why?
| | Phenotype | 1 | 2015 | 3196 | 0.070 |
Why?
| | Body Mass Index | 1 | 2015 | 2389 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 890 | 0.060 |
Why?
| | Inflammation | 1 | 2015 | 2837 | 0.060 |
Why?
| | Homocysteine | 1 | 2024 | 156 | 0.050 |
Why?
| | Folic Acid | 1 | 2024 | 186 | 0.050 |
Why?
| | Carbon | 1 | 2024 | 216 | 0.050 |
Why?
| | Type C Phospholipases | 1 | 2002 | 74 | 0.050 |
Why?
| | United Kingdom | 1 | 2023 | 318 | 0.050 |
Why?
| | Isoenzymes | 1 | 2002 | 304 | 0.050 |
Why?
| | Male | 6 | 2024 | 67762 | 0.050 |
Why?
| | Disease Models, Animal | 3 | 2019 | 4295 | 0.040 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 622 | 0.040 |
Why?
| | Postmenopause | 1 | 2020 | 366 | 0.040 |
Why?
| | Middle Aged | 1 | 2019 | 33479 | 0.030 |
Why?
| | Vasodilation | 1 | 2020 | 499 | 0.030 |
Why?
| | Connective Tissue | 1 | 2016 | 36 | 0.030 |
Why?
| | Oxidative Stress | 2 | 2013 | 1317 | 0.030 |
Why?
| | Pelvic Organ Prolapse | 1 | 2016 | 51 | 0.030 |
Why?
| | Hemoglobin, Sickle | 1 | 2013 | 19 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2016 | 844 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 927 | 0.030 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2013 | 204 | 0.020 |
Why?
| | NF-kappa B | 1 | 2016 | 691 | 0.020 |
Why?
| | Thioredoxin Reductase 2 | 1 | 2011 | 2 | 0.020 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2011 | 27 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2011 | 307 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2016 | 828 | 0.020 |
Why?
| | PC12 Cells | 1 | 2002 | 40 | 0.010 |
Why?
| | Phospholipase C gamma | 1 | 2002 | 29 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 2002 | 145 | 0.010 |
Why?
| | Apoptosis | 1 | 2011 | 2553 | 0.010 |
Why?
| | RNA, Double-Stranded | 1 | 2002 | 57 | 0.010 |
Why?
| | Catalysis | 1 | 2002 | 307 | 0.010 |
Why?
| | Aged | 1 | 2020 | 23961 | 0.010 |
Why?
| | Calcium | 1 | 2002 | 1199 | 0.010 |
Why?
|
|
Hurt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|